Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Amylyx Pharmaceuticals, Inc. (AMLX) had Weighted-Average Shares Outstanding (Basic) of 67.23M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
$380.79M |
|
$49.27M |
|
$25.44M |
|
$355.35M |
|
$341.98M |
|
$38.80M |
|
$15.49M |
|
$54.30M |
|
$54.30M |
|
$49.27M |
|
$49.27M |
|
$49.27M |
|
$49.27M |
|
$38.80M |
|
$29.95M |
|
Weighted-Average Shares Outstanding (Basic) |
67.23M |
69.99M |
|
$0.73 |
|
$0.70 |
|
Balance Sheet Financials | |
$464.67M |
|
$2.69M |
|
$52.79M |
|
$517.45M |
|
$82.04M |
|
-- |
|
$1.98M |
|
$84.02M |
|
$433.43M |
|
$433.43M |
|
$433.43M |
|
67.71M |
|
Cash Flow Statement Financials | |
$11.92M |
|
$92.05M |
|
$3.54M |
|
$63.24M |
|
$170.92M |
|
$107.67M |
|
$37.16M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
5.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
93.32% |
|
10.19% |
|
10.19% |
|
7.87% |
|
14.26% |
|
12.94% |
|
$10.68M |
|
-- |
|
-- |
|
-- |
|
0.74 |
|
0.66 |
|
9.51 |
|
38.39 |
|
11.37% |
|
11.37% |
|
9.52% |
|
11.37% |
|
$6.40 |
|
$0.15 |
|
$0.17 |